Structures by: Arunkashi H. K.
Total: 11
Nicotinaldehyde [2,8-bis(trifluoromethyl)quinolin-4-yl]hydrazone monohydrate
C17H10F6N4,H2O
Acta Crystallographica Section E (2010) 66, 9 o2237-o2238
a=21.103(4)Å b=15.120(3)Å c=12.537(3)Å
α=90.00° β=118.633(3)° γ=90.00°
4-Ethoxyphenyl 4-[(methoxycarbonyl)oxy]benzoate
C17H16O6
Acta Crystallographica Section E (2010) 66, 12 o3074
a=11.7397(5)Å b=16.9703(6)Å c=7.9324(3)Å
α=90.00° β=96.949(4)° γ=90.00°
3,4-Dimethoxybenzaldehyde [2,8-bis(trifluoromethyl)quinolin-4-yl]hydrazone
C20H15F6N3O2
Acta Crystallographica Section E (2010) 66, 7 o1742
a=7.0359(6)Å b=8.9617(8)Å c=15.5315(14)Å
α=90.1540(10)° β=93.9510(10)° γ=96.4490(10)°
Bis[<i>N</i>,<i>N</i>-dimethyl-1-(10<i>H</i>-pyrido[3,2- <i>b</i>][1,4]benzothiazin-10-yl)propan-2-aminium] tetrakis(thiocyanato-κ<i>N</i>)cobaltate(II)
2(C16H20N3S),C4CoN4S42
Acta Crystallographica Section E (2010) 66, 7 m772-m773
a=25.2420(4)Å b=11.4357(2)Å c=14.5939(2)Å
α=90.00° β=98.5570(10)° γ=90.00°
Ethyl 3-oxo-3<i>H</i>-benzo[<i>f</i>]chromene-2-carboxylate
C16H12O4
Acta Crystallographica Section E (2010) 66, 10 o2658
a=14.6716(11)Å b=4.5190(5)Å c=19.3874(18)Å
α=90.00° β=90.218(7)° γ=90.00°
6-Chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline
C13H9ClF3N
Acta Crystallographica Section E (2011) 67, 3 o564
a=13.8482(19)Å b=5.0534(8)Å c=18.048(3)Å
α=90.00° β=107.503(17)° γ=90.00°
2-[4-(Morpholin-4-ylmethyl)phenyl]benzonitrile
C18H18N2O
Acta Crystallographica Section E (2013) 69, 1 o129
a=21.1079(5)Å b=8.13580(10)Å c=9.0793(2)Å
α=90.00° β=100.8330(10)° γ=90.00°
(3-Oxo-3<i>H</i>-benzo[<i>f</i>]chromen-1-yl)methyl piperidine-1-carbodithioate
C20H19NO2S2
Acta Crystallographica Section E (2012) 68, 11 o3167
a=12.4508(3)Å b=10.1924(3)Å c=14.0188(4)Å
α=90.00° β=100.953(2)° γ=90.00°
(6-Methoxy-2-oxo-2<i>H</i>-chromen-4-yl)methyl morpholine-4-carbodithioate
C16H17NO4S2
Acta Crystallographica Section E (2013) 69, 2 o192
a=7.0026(5)Å b=7.9939(6)Å c=14.8033(11)Å
α=75.433(4)° β=86.642(4)° γ=78.355(4)°
1-(4-Chlorophenyl)-1<i>H</i>-1,2,4-triazol-5(4<i>H</i>)-one
C8H6ClN3O
Acta Crystallographica Section E (2014) 70, 4 o499
a=6.5791(4)Å b=7.2663(4)Å c=9.3342(5)Å
α=80.121(4)° β=85.042(4)° γ=70.235(4)°
<i>N</i>-(6-Chloro-1-methyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)benzenesulfonamide
C13H11ClN4O2S
Acta Crystallographica Section E (2014) 70, 4 o445
a=13.1045(4)Å b=14.7259(5)Å c=14.6953(6)Å
α=90.00° β=95.127(3)° γ=90.00°